Margaret R. Spitz
#117,123
Most Influential Person Now
Margaret R. Spitz's AcademicInfluence.com Rankings
Margaret R. Spitzmedical Degrees
Medical
#1702
World Rank
#2069
Historical Rank
Oncology
#84
World Rank
#88
Historical Rank
Epidemiology
#268
World Rank
#285
Historical Rank

Margaret R. Spitzphilosophy Degrees
Philosophy
#5138
World Rank
#7867
Historical Rank
Logic
#2467
World Rank
#3463
Historical Rank

Download Badge
Medical Philosophy
Margaret R. Spitz's Degrees
- Doctorate Medicine University of Texas Medical Branch
Why Is Margaret R. Spitz Influential?
(Suggest an Edit or Addition)Margaret R. Spitz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Somatic mutations affect key pathways in lung adenocarcinoma (2008) (2640)
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 (2008) (1262)
- Characterizing the cancer genome in lung adenocarcinoma (2007) (1122)
- Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. (1999) (581)
- Common 5p15.33 and 6p21.33 variants influence lung cancer risk (2008) (550)
- A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. (2009) (532)
- The PhenX Toolkit: Get the Most From Your Measures (2011) (520)
- Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. (2000) (520)
- Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. (2001) (519)
- Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
- Telomere dysfunction: a potential cancer predisposition factor. (2003) (487)
- Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD (2010) (400)
- A risk model for prediction of lung cancer. (2007) (389)
- Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. (1995) (374)
- Genetic susceptibility to lung cancer: the role of DNA damage and repair. (2003) (359)
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes (2017) (353)
- Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. (2008) (349)
- Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. (1999) (332)
- Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2014) (322)
- The landscape of recombination in African Americans (2011) (312)
- Reduced DNA repair capacity in lung cancer patients. (1996) (310)
- Marijuana use and increased risk of squamous cell carcinoma of the head and neck. (1999) (300)
- Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. (2006) (278)
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward (2006) (272)
- Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. (2002) (270)
- Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. (1989) (267)
- p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. (2002) (261)
- Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. (2000) (257)
- Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. (2009) (244)
- Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. (1998) (244)
- A Meta-Analysis Identifies New Loci Associated with Body Mass index in Individuals of African Ancestry (2013) (244)
- Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. (2008) (240)
- The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. (2008) (238)
- Phytoestrogen intake and prostate cancer: a case-control study using a new database. (1999) (234)
- A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. (2001) (232)
- Familial patterns of prostate cancer: a case-control analysis. (1991) (227)
- Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. (2010) (224)
- Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population (2000) (223)
- Descriptive epidemiology and risk factors for head and neck cancer. (2004) (220)
- From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. (2003) (207)
- XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. (2000) (205)
- Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. (1997) (204)
- A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. (2002) (200)
- Reduced DNA repair capacity in head and neck cancer patients. (1998) (199)
- Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. (2010) (198)
- Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls (2012) (196)
- Birthplace, Years of Residence in the United States, and Obesity Among Mexican‐American Adults (2007) (187)
- Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. (2005) (185)
- XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. (2003) (182)
- Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. (1989) (181)
- Assessing the function of genetic variants in candidate gene association studies (2004) (180)
- An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. (2002) (178)
- Epidemiology and risk factors for head and neck cancer. (1994) (176)
- Lung carcinoma in former smokers (1996) (176)
- Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. (2002) (174)
- Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. (2011) (170)
- Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. (2006) (169)
- Leptin and prostate cancer (2001) (166)
- Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. (2003) (158)
- Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. (1995) (158)
- Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. (2008) (157)
- p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. (1995) (157)
- Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) (2003) (152)
- An Expanded Risk Prediction Model for Lung Cancer (2008) (148)
- Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. (1990) (147)
- Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer (2006) (146)
- Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. (2006) (145)
- Polymorphisms of 5,10‐methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case‐control study (2001) (144)
- Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. (2003) (144)
- Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States (2009) (144)
- Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. (1997) (144)
- Smoking, DNA repair capacity and risk of nonsmall cell lung cancer (2003) (141)
- Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. (2000) (141)
- Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. (2012) (140)
- Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. (2001) (140)
- Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers (2007) (139)
- Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. (2007) (137)
- Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. (2012) (137)
- Hormone Replacement Therapy and Lung Cancer Risk (2004) (135)
- Case-control study of diet and prostate cancer in China (1998) (135)
- An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. (2001) (133)
- Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. (1984) (132)
- Alterations of p53, cyclin D1, rb, and H‐ras in human oral carcinomas related to tobacco use (1998) (128)
- Glutathione s-transferase genotypes as risk factors for head and neck cancer. (1995) (127)
- Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. (2003) (126)
- Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck (2002) (125)
- Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignancies (2004) (124)
- Neuroblastoma and paternal occupation. A case-control analysis. (1985) (123)
- Analysis of human papillomavirus DNA in oral squamous cell carcinomas. (1993) (121)
- Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. (1997) (121)
- A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research (2014) (121)
- P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. (2002) (120)
- Cancer and age. (1989) (120)
- The development of breast carcinoma in women with thyroid carcinoma (2001) (120)
- Genetic susceptibility to head and neck squamous cell carcinoma. (1996) (118)
- Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. (1994) (118)
- Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. (1996) (117)
- Glutathione‐S‐transferase polymorphisms and risk of squamous‐cell carcinoma of the head and neck (1999) (117)
- Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
- Molecular epidemiology and retinoid chemoprevention of head and neck cancer. (1997) (115)
- An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology (2004) (115)
- Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer (2006) (114)
- DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. (2002) (114)
- Genetic susceptibility to cancer: ICRP Publication 79 (1993) (113)
- Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. (1993) (111)
- International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle Pathways (2008) (110)
- Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. (1997) (109)
- Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis (1988) (109)
- Dietary phytoestrogens and lung cancer risk. (2005) (107)
- Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. (1995) (107)
- Is there a genetic basis for lung cancer susceptibility? (1999) (106)
- Molecular epidemiology, cancer-related symptoms, and cytokines pathway. (2008) (101)
- Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. (1997) (101)
- Body mass index and risk of lung cancer among never, former, and current smokers. (2012) (100)
- Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans (2008) (100)
- Mutagen sensitivity: a biological marker of cancer susceptibility. (1991) (99)
- Never smokers and lung cancer risk: A case‐control study of epidemiological factors (2006) (98)
- Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. (2002) (96)
- Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. (2004) (96)
- Evolutionary evidence of the effect of rare variants on disease etiology (2011) (96)
- Genetic variants of myeloperoxidase and lung cancer risk. (2000) (95)
- Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. (2000) (94)
- A myeloperoxidase polymorphism associated with reduced risk of lung cancer. (2002) (93)
- Genetic instability in bladder cancer assessed by the comet assay. (2003) (93)
- Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. (2007) (92)
- Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. (2004) (92)
- Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
- Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer (2010) (91)
- Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors (2003) (89)
- Association between low dietary folate intake and suboptimal cellular DNA repair capacity. (2003) (88)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- An association between NQO1 genetic polymorphism and risk of bladder cancer. (2003) (86)
- Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. (2011) (86)
- Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. (2001) (85)
- Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms (2005) (84)
- Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. (2003) (84)
- Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. (2001) (82)
- Adenocarcinoma of the lung in young patients (2000) (82)
- Risk factors for major salivary gland carcinoma. A case‐comparison study (1984) (81)
- Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. (2012) (81)
- Aggregation of cancer among relatives of never‐smoking lung cancer patients (2007) (80)
- Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study (2008) (80)
- Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT) (2004) (80)
- In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. (1996) (80)
- Genetic polymorphisms in DNA base‐excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck (2007) (79)
- Risk for smoking-related cancer among relatives of lung cancer patients. (2003) (79)
- Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. (2002) (78)
- Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and Neck (2006) (78)
- Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer (2007) (78)
- IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans (2015) (78)
- Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. (2005) (78)
- Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review (2008) (78)
- Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. (2000) (77)
- Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry—A Meta‐Analysis of Chromosome 15q25 (2012) (77)
- Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk (2010) (76)
- Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. (2010) (76)
- Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers (2008) (76)
- Wood dust exposure and the association with lung cancer risk. (2005) (75)
- Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. (1998) (75)
- Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung Cancer (2006) (74)
- Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. (2005) (74)
- Mutagen sensitivity: a genetic predisposition factor for cancer. (2007) (74)
- CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. (2015) (74)
- A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. (1995) (73)
- Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. (2001) (73)
- Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States) (1997) (73)
- Comparison of discriminatory power and accuracy of three lung cancer risk models (2010) (73)
- Dietary zinc, copper and selenium, and risk of lung cancer (2006) (72)
- Childhood nervous system tumours: an assessment of risk associated with paternal occupations involving use, repair or manufacture of electrical and electronic equipment. (1989) (72)
- Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
- Variant alleles of the D2 dopamine receptor gene and obesity (2000) (72)
- Mutagen sensitivity has high heritability: evidence from a twin study. (2006) (72)
- Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. (2002) (72)
- Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck Cancer (2004) (71)
- Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction (2013) (71)
- Polymorphisms of Methionine Synthase and Methionine Synthase Reductase and Risk of Squamous Cell Carcinoma of the Head and Neck: a Case-Control Analysis (2005) (71)
- Reproductive and Hormonal Factors and Lung Cancer Risk in the NIH-AARP Diet and Health Study Cohort (2011) (70)
- Ethnic patterns of thyroid cancer incidence in the United States, 1973‐1981 (1988) (70)
- MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. (2006) (70)
- A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls (1998) (69)
- Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. (1998) (69)
- DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. (1996) (69)
- Risk factor analysis among men referred for possible acquired immune deficiency syndrome. (1985) (68)
- Projecting individualized probabilities of developing bladder cancer in white individuals. (2007) (68)
- Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-α-308 G/A IL6-174G/C and IL8-251T/A (2007) (67)
- Expression of Telomere-Associated Genes as Prognostic Markers for Overall Survival in Patients with Non–Small Cell Lung Cancer (2006) (66)
- PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. (2011) (66)
- Nucleotide Excision Repair Pathway Genes and Oral Premalignant Lesions (2007) (65)
- Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q (1999) (65)
- p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer (2004) (65)
- Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: A cross-sectional analysis (2008) (65)
- Association between glutathione S‐transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma (2006) (65)
- Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. (2011) (65)
- Maternal BMI and Country of Birth as Indicators of Childhood Obesity in Children of Mexican Origin (2007) (65)
- Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. (2003) (64)
- Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. (1998) (64)
- In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. (2005) (64)
- Salivary gland cancer. A case-control investigation of risk factors. (1990) (64)
- Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. (2002) (64)
- Analysis of aromatic DNA adducts and 7,8‐dihydro‐8‐oxo‐ 2′‐deoxyguanosine in lymphocyte DNA from a case–control study of lung cancer involving minority populations (2000) (63)
- Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. (2003) (63)
- Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients (2009) (63)
- Incidence and descriptive features of testicular cancer among United States whites, blacks, and hispanics, 1973–1982 (1986) (62)
- Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants (2009) (62)
- Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck (2007) (62)
- D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. (2000) (62)
- Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. (1996) (62)
- A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: A case‐control analysis (2002) (62)
- International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. (2010) (62)
- Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. (1997) (62)
- Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes (2012) (61)
- Prognostic significance of ataxia‐telangiectasia mutated, DNA‐dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86‐kD subunit expression in patients with nonsmall cell lung cancer (2008) (61)
- Childhood nervous system tumors--an evaluation of the association with paternal occupational exposure to hydrocarbons. (1987) (61)
- Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. (2014) (60)
- MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. (2010) (59)
- Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. (2013) (59)
- The role of DNA repair capacity in susceptibility to lung cancer: A review (1997) (59)
- Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. (1998) (58)
- Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: A case‐control analysis (2005) (58)
- Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. (2006) (58)
- DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. (2002) (58)
- DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. (2011) (58)
- Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. (2015) (57)
- Lung tissue microbial profile in lung cancer is distinct from emphysema. (2018) (57)
- A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. (1994) (57)
- Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. (2004) (57)
- Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. (1985) (57)
- Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. (2012) (56)
- Thymidylate Synthase 5′- and 3′-Untranslated Region Polymorphisms Associated with Risk and Progression of Squamous Cell Carcinoma of the Head and Neck (2004) (56)
- Research methodology: Strengthening causal interpretations of nonexperimental data (2004) (56)
- Lung cancer chemoprevention: an integrated approach. (2001) (56)
- Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer (2005) (56)
- Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case–control analysis (2005) (56)
- Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. (2002) (55)
- Dietary magnesium and DNA repair capacity as risk factors for lung cancer. (2008) (55)
- p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. (2003) (55)
- Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. (2001) (54)
- A recurrent mutation in PARK2 is associated with familial lung cancer. (2015) (54)
- XPD / ERCC 2 polymorphisms and risk of head and neck cancer : a case-control analysis (2000) (54)
- Genetic susceptibility to tobacco carcinogenesis. (1999) (54)
- Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. (1993) (54)
- 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. (2006) (54)
- Integrative epidemiology: from risk assessment to outcome prediction. (2005) (54)
- Genome-wide gene–environment interaction analysis for asbestos exposure in lung cancer susceptibility (2012) (53)
- Wnt Signaling Pathway Pharmacogenetics in Non-Small Cell Lung Cancer (2014) (53)
- Reduced DNA Repair Capacity for Removing Tobacco Carcinogen–Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics (2010) (53)
- Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. (2000) (53)
- Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. (2004) (52)
- Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study (2010) (52)
- Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era (2013) (52)
- Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens pooled analysis (2007) (52)
- The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. (2001) (52)
- Death receptor 4 and bladder cancer risk. (2003) (51)
- The Influence of Tumor Necrosis Factor-α −308 G/A and IL-6 −174 G/C on Pain and Analgesia Response in Lung Cancer Patients Receiving Supportive Care (2008) (51)
- Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. (1990) (51)
- Polymorphisms of DNA repair gene XRCC 1 in squamous cell carcinoma of the head and neck (1999) (50)
- Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation (2007) (50)
- Combined Effects of the p53 and p73 Polymorphisms on Lung Cancer Risk (2006) (49)
- Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes (2013) (48)
- Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy (2008) (48)
- Chipping away at the genetics of smoking behavior (2010) (48)
- Association between the V109G Polymorphism of the p27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (48)
- Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. (2006) (48)
- Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer (2008) (48)
- The evolving discipline of molecular epidemiology of cancer. (2010) (48)
- Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. (2005) (47)
- Development of common data elements: the experience of and recommendations from the early detection research network (2003) (47)
- Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. (2003) (47)
- Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation (2010) (47)
- A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. (1995) (46)
- Vasectomy and prostate cancer risk in China. (1994) (46)
- Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention (2012) (46)
- Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. (2013) (46)
- Epidemiologic determinants of clinically relevant prostate cancer (2000) (46)
- Smoking-related genomic signatures in non-small cell lung cancer. (2008) (45)
- An association between a NQO1 genetic polymorphism and risk of lung cancer. (2005) (45)
- Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. (2011) (45)
- Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-82. (1986) (44)
- Dietary carotenoids and genetic instability modify bladder cancer risk. (2004) (44)
- Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2008) (44)
- Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk (2005) (44)
- Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. (2009) (43)
- In vitro BPDE‐induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck (2001) (43)
- “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities (2013) (43)
- Exposure to Smoking Imagery in the Movies and Experimenting with Cigarettes among Mexican Heritage Youth (2009) (43)
- Comparison of Pathway Analysis Approaches Using Lung Cancer GWAS Data Sets (2012) (42)
- Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. (2001) (42)
- Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. (1998) (42)
- Bladder cancer risk as modified by family history and smoking (2006) (42)
- Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. (1995) (42)
- Ethyl alcohol as a cocarcinogen with special reference to the aerodigestive tract: a cytogenetic study. (1991) (41)
- Relationship Between Plasma Carotenoids and Prostate Cancer (2005) (41)
- Age-related differences in factors associated with smoking initiation (2007) (40)
- Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge (2009) (40)
- Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. (2001) (39)
- Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. (1999) (39)
- Psychosocial risk and correlates of early menarche in Mexican-American girls. (2011) (39)
- Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. (1998) (39)
- Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer (1999) (39)
- Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3 (1999) (39)
- A case-control study of prostate cancer. (1989) (39)
- Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non‐Hispanic whites (2002) (39)
- Neuroblastoma: case-control analysis of birth characteristics. (1985) (39)
- Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. (2016) (38)
- An epidemiologic study of early onset lung cancer. (2006) (38)
- Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies (2010) (37)
- Complex segregation analysis reveals a multigene model for lung cancer (2004) (37)
- CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. (2015) (37)
- Dietary α‐, β‐, γ‐ and δ‐tocopherols in lung cancer risk (2008) (37)
- Evaluation of glutathione S‐transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early‐stage head and neck cancer (2006) (36)
- Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. (2005) (36)
- Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers (2010) (36)
- Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. (2002) (36)
- No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. (2004) (36)
- DNA Repair Capacity and Lung Cancer Risk in Never Smokers (2008) (36)
- A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. (1996) (35)
- Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis (2016) (35)
- Variants in folate pathway genes as modulators of genetic instability and lung cancer risk (2011) (35)
- Case-Control Analysis of Dietary Folate and Risk of Bladder Cancer (2005) (35)
- ATM sequence variants associate with susceptibility to non‐small cell lung cancer (2007) (34)
- Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. (1999) (34)
- Epidemiology, biology, and chemoprevention of aerodigestive cancer (1994) (34)
- Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis (2006) (34)
- Role of Selected Genetic Variants in Lung Cancer Risk in African Americans (2013) (34)
- Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans (2012) (34)
- Gender Difference in Smoking Effect on Chromosome Sensitivity to Gamma Radiation in a Healthy Population (2000) (34)
- Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. (2011) (34)
- Distinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking (2013) (33)
- Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. (2011) (33)
- AACR Cancer Progress Report 2012 (2012) (33)
- Smoking Initiation Among Mexican Heritage Youth and the Roles of Family Cohesion and Conflict. (2015) (32)
- The Biology of Tobacco and Nicotine: Bench to Bedside (2005) (32)
- Dietary Patterns Affect Lung Cancer Risk in Never Smokers (2011) (32)
- γ-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer (2001) (32)
- Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites (2006) (32)
- Increased plasma levels of angiogenin and the risk of bladder carcinoma (2005) (32)
- Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. (2005) (32)
- Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). (2013) (32)
- Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. (2008) (32)
- Global Assessment of Genetic Variation Influencing Response to Retinoid Chemoprevention in Head and Neck Cancer Patients (2011) (32)
- Investigating Multiple Candidate Genes and Nutrients in the Folate Metabolism Pathway to Detect Genetic and Nutritional Risk Factors for Lung Cancer (2013) (31)
- Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. (1998) (31)
- Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. (2007) (31)
- Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2013) (31)
- Multistage Analysis of Variants in the Inflammation Pathway and Lung Cancer Risk in Smokers (2012) (31)
- XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations (2003) (31)
- Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. (2002) (31)
- Integrative cancer epidemiology--the next generation. (2012) (30)
- Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients (2004) (30)
- CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu Polymorphisms Are Not Associated with Risk of Squamous Cell Carcinoma of the Head and Neck (2005) (30)
- Whole exome sequencing analysis in severe chronic obstructive pulmonary disease (2018) (30)
- Admixture mapping of lung cancer in 1812 African-Americans. (2011) (29)
- Seizure 6-like (SEZ6L) gene and risk for lung cancer. (2007) (29)
- Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. (1995) (28)
- The Cytokinesis-Blocked Micronucleus Assay as a Strong Predictor of Lung Cancer: Extension of a Lung Cancer Risk Prediction Model (2014) (28)
- Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation Analysis (2008) (28)
- Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk (2012) (28)
- Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. (2008) (28)
- Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. (2009) (28)
- Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. (2010) (27)
- Mutagen sensitivity as a marker of cancer risk. (1994) (27)
- In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. (1993) (27)
- Mutagen sensitivity exhibits a dose-response relationship in case-control studies. (1996) (27)
- Influence of subjective social status on the relationship between positive outcome expectations and experimentation with cigarettes. (2009) (27)
- An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. (2011) (27)
- A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer (2005) (26)
- Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. (2000) (26)
- Sensation‐seeking genes and physical activity in youth (2013) (26)
- Joint Effects of Dietary Trace Metals and DNA Repair Capacity in Lung Cancer Risk (2007) (25)
- Cognitive Susceptibility to Smoking: Two Paths to Experimenting among Mexican Origin Youth (2009) (25)
- Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. (2007) (25)
- Genetic variations in cell‐cycle pathway and the risk of oral premalignant lesions (2008) (25)
- The development of a comprehensive, institution-based patient risk evaluation program: I. Development, content, and data management. (1988) (25)
- Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck (1995) (24)
- Incidence of prostate cancer and marital status. (1987) (24)
- Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk (2006) (24)
- Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer (2016) (23)
- 3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC) (2008) (23)
- Cancer prevention practices among Texas primary care physicians. (1992) (23)
- Chromosome 5 aberrations and genetic predisposition to lung cancer (1998) (23)
- Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case‐control analysis (2003) (22)
- Comparison of Haplotype Inference Methods Using Genotypic Data from Unrelated Individuals (2004) (22)
- Seasonal diagnosis of Hodgkin's disease among young adults. (1985) (22)
- E‐cadherin promoter polymorphism (C‐160A) and risk of recurrence in patients with superficial bladder cancer (2006) (22)
- Myeloperoxidase promoter region polymorphism and lung cancer risk. (2003) (21)
- Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. (2002) (20)
- Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. (2002) (20)
- Mutagen sensitivity as a marker of cancer susceptibility (1996) (20)
- Genetic Susceptibility for Lung Cancer: Interactions with Gender and Smoking History and Impact on Early Detection Policies (2003) (20)
- Month-of-birth and incidence of acute lymphoblastic leukemia in children. (1996) (20)
- A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. (2007) (20)
- Smoking affects treatment outcome in patients with advanced non-small cell lung cancer. (2004) (19)
- A smoking‐based carcinogenesis model for lung cancer risk prediction (2011) (19)
- Association between malignancies of the upper aerodigestive tract and uterine cervix (1992) (19)
- The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. (1988) (19)
- Use of the Cytokinesis-Blocked Micronucleus Assay to Detect Gender Differences and Genetic Instability in a Lung Cancer Case–Control Study (2012) (19)
- Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. (2019) (19)
- Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer (2006) (19)
- Three measures of mutagen sensitivity in a cancer-free population. (1999) (19)
- The associations of body image, anxiety, and smoking among Mexican-origin youth. (2013) (19)
- D 2 Dopamine Receptor Gene Polymorphisms among African-Americans and Mexican-Americans : A Lung Cancer Case-Control Study 1 (2000) (18)
- Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. (2005) (18)
- Low incidence of familial breast cancer among Hispanic women (1992) (18)
- Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case–control analysis (2005) (18)
- Cigarette smoking patterns of cancer patients. (1990) (18)
- XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. (2002) (18)
- Association of smoking with tumor size at diagnosis in non-small cell lung cancer. (2011) (17)
- Cigarette Experimentation in Mexican Origin Youth: Psychosocial and Genetic Determinants (2011) (17)
- Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. (2011) (17)
- Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis (2007) (17)
- Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer (2009) (17)
- Chromosomal Instability in Peripheral Blood Lymphocytes and Risk of Prostate Cancer (2005) (17)
- Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: A case‐control study (2001) (17)
- Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. (2001) (17)
- Methyl‐CpG‐binding domain 2 (2004) (16)
- GPC5 rs2352028 variant and risk of lung cancer in never smokers. (2010) (16)
- Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer (2018) (16)
- Chromosome instability and risk of squamous cell carcinomas of head and neck. (2008) (15)
- Salivary gland cancer and risk of subsequent skin cancer (1990) (15)
- Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. (2008) (15)
- Human sensitivity to PhIP: a novel marker for prostate cancer risk. (2006) (15)
- A Case–Control Study of a Sex-Specific Association between a 15q25 Variant and Lung Cancer Risk (2011) (15)
- Questionable relationship between cholecystectomy and colon cancer (1985) (15)
- A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. (1997) (15)
- Nitrite inhalants: historical perspective. (1988) (14)
- Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. (1998) (14)
- Heme‐related gene expression signatures of meat intakes in lung cancer tissues (2014) (14)
- A Functional Variant of Tandem Repeats in Human Telomerase Gene Was Associated with Survival of Patients with Early Stages of Non–Small Cell Lung Cancer (2010) (14)
- Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort (2012) (14)
- Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. (2011) (13)
- Multiple Primary Cancer Risk in Patients with Major Salivary Gland Carcinoma (1985) (13)
- Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on γ-Radiation (2007) (13)
- Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. (1998) (13)
- Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study (2012) (13)
- Self-Rated Health Among Adult Women of Mexican Origin (2006) (13)
- Season-of-birth and acute leukemia of infancy. (1989) (13)
- Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment (2022) (13)
- Comparative efficacy as antioxidants between ascorbic acid and epigallocatechin gallate on cells of two human lymphoblastoid lines. (2001) (12)
- Experimenting with cigarettes and physical activity among Mexican origin youth: a cross sectional analysis of the interdependent associations among sensation seeking, acculturation, and gender (2012) (12)
- Erratum: Phytoestrogen intake and prostate cancer: A case-control study using a new database (Nutrition and Cancer (1999) 33:1 (22-23)) (2000) (12)
- Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans (2018) (12)
- Informed Genome‐Wide Association Analysis With Family History As a Secondary Phenotype Identifies Novel Loci of Lung Cancer (2015) (12)
- Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans (2012) (12)
- Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans (2016) (12)
- DNA Repair Gene ERCC 1 and ERCC 2 / XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck (2002) (12)
- Leukemia and cigarette smoking (1990) (12)
- DNA repair and genomic instability in tobacco induced malignancies of the lung and upper aerodigestive tract (1998) (11)
- Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. (2015) (11)
- Shared cytogenetic abnormalities in lung-tumors and corresponding peripheral-blood lymphocytes. (1995) (11)
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. (2011) (11)
- Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. (2000) (11)
- Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. (1987) (11)
- Derived SNP Alleles are Used More Frequently than Ancestral Alleles as Risk-associated Variants in Common Human Diseases (2012) (11)
- BPDE‐induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk (2002) (11)
- Benzo[a]pyrene diol epoxide‐induced 9p21 aberrations associated with genetic predisposition to bladder cancer (2004) (10)
- Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. (2021) (10)
- The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. (2014) (10)
- Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis (2013) (10)
- Risk factors and genetic susceptibility. (1995) (10)
- Exposure to Pro-tobacco Messages and Smoking Status Among Mexican Origin Youth (2014) (10)
- High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy (2005) (10)
- Chapter 11: Rice‐MD Anderson Lung Cancer Model (2012) (9)
- A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. (2011) (9)
- PACE-setting research (1997) (9)
- Gender differences in sociodemographic and behavioral influences of physical activity in Mexican-origin adolescents. (2012) (9)
- Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. (1996) (9)
- Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy (2014) (9)
- Association between the V 109 G Polymorphism of the p 27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (9)
- Re: "Cancer mortality among US men and women with asthma and hay fever". (2006) (9)
- Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth (2015) (8)
- Subgroup report: head and neck cancer. (2004) (8)
- Cotinine conundrum--a step forward but questions remain. (2012) (8)
- Analysis of aromatic DNA adducts and 7,8‐dihydro‐8‐oxo‐2′ deoxyguanosine in lymphocyte DNA from a case‐control study of lung cancer involving minority populations (2000) (8)
- Rare deleterious germline variants and risk of lung cancer (2021) (8)
- Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. (2001) (8)
- Genetic instability of specific chromosomes associated with a family history of cancer. (2002) (8)
- A Risk Prediction Model for Smoking Experimentation in Mexican American Youth (2014) (7)
- Abstract 2931: Inherited variation at chromosome 12p13.33 includingRAD52influences squamous cell lung carcinoma risk (2012) (7)
- Sex chromosome abnormalities in lung cancer patients. (1996) (7)
- Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. (2005) (7)
- A case‐control analysis of lymphocytic chromosome 9 aberrations in lung cancer (2002) (7)
- Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population. (1998) (7)
- Profiles of cigarette smoking among patients in a cancer center. (1988) (7)
- Combined Effects of the p 53 and p 73 Polymorphisms on Lung Cancer Risk (2006) (7)
- Subfertility: an etiologic factor in development of testicular cancer? (1987) (6)
- Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. (1997) (6)
- B7-07: Deletion of chromosome 10q detected by Fluorescent In Situ Hybridization (FISH) is a potential new tool for early detection of Non Small Cell Lung Cancer (NSCLC) (2007) (6)
- Genetic Susceptibility to Lung Cancer (2003) (6)
- Prematurity and risk of childhood cancer. (1986) (6)
- Association of Genetic Variants of O 6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites (2006) (6)
- Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer (2022) (6)
- Molecular dosimeters of smoking damage in the lung. (1999) (6)
- Assessing environmental and occupational risk factors for lung cancer in Mexican–Americans (2010) (6)
- Strategies to Identify Pharmacogenomic Biomarkers: Candidate Gene, Pathway-Based, and Genome-Wide Approaches (2008) (6)
- Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. (2000) (6)
- Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer (2004) (5)
- Improving residents' knowledge of cancer prevention: are physicians prepared for prevention? (2009) (5)
- Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. (2011) (5)
- A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. (2010) (5)
- Genome-wide scan of 29,141 African Americans finds no evidence of selection since admixture (2013) (5)
- Education and lung cancer among never smokers. (2014) (4)
- Strategies to Improve Healthcare Websites (2006) (4)
- Occupational exposure to silica and cancer risk (2004) (4)
- Recommendations for Cancer Prevention (1992) (4)
- Self-Reported Prior Lung Diseases as Risk Factors for Non-small Cell Lung Cancer in Mexican Americans (2013) (4)
- Risk profiles of women with cervical neoplasia. (1991) (4)
- Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2017) (4)
- Chapter 3. Lung Cancer Susceptibility and Risk Assessment Models (2008) (3)
- Excess leukemia and multiple myeloma in a mining county in northeast Texas. (1994) (3)
- Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2009) (3)
- p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. (2012) (3)
- Hamilton et al. Respond to “Consolidating Data Harmonization” (2011) (3)
- Viewing images of alcohol use in PG-13-rated movies and alcohol initiation in Mexican-heritage youth (2019) (3)
- O-055 Dietary phytoestrogens and lung cancer risk (2005) (3)
- Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations (1997) (3)
- Cancer risk and early detection assessment. (1993) (3)
- Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry—A Meta‐Analysis of Chromosome 15q25 (2012) (3)
- Lower lung cancer rates in Jewish smokers in Israel and the USA (2015) (2)
- Epidemiology--found in translation. (2011) (2)
- Genetic and environmental interactions as risks for aerodigestive cancers. (1992) (2)
- Pelvic Adhesions in Intrauterine Device Users (1988) (2)
- Epidemiologic similarities leading to etiologic hypotheses. (1987) (2)
- Lung cancer risk factors in a minority population (2006) (2)
- Misclassification of Body Mass Index (BMI) Using Self-Reported Weight and Height in an Urban Mexican-American Population (2005) (2)
- COMMENT ON: BENZOAPYRENE DIOL EPOXIDE AND BLEOMYCIN SENSITIVITY AND SUSCEPTIBILITY TO CANCER OF UPPER AERODIGESTIVE TRACT. AUTHORS' REPLY (1999) (2)
- Erratum: Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (Modern Pathology (2008) 21 (950-960) DOI:10.1038/modpathol.2008.71) (2008) (2)
- Serum Insulin-like Growth Factor (IGF) and IGF-binding Protein Levels and Risk of Lung Cancer (2002) (2)
- Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. (1997) (2)
- Maternal current smoking: concordance between adolescent proxy and mother's self-report. (2009) (2)
- Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. (2005) (2)
- Lung cancer after breast cancer: the role of radiation therapy and smoking (1999) (2)
- An Informatics Tool to Assess Individualized Colon Cancer Risk (2005) (2)
- Irradiation‐induced telomerase activity and the risk of lung cancer (2007) (2)
- Fine-mapping of the 5 p 15 . 33 , 6 p 22 . 1p 21 . 31 , and 15 q 25 . 1 Regions Identi fi es Functional and Histology-Speci fi c Lung Cancer Susceptibility Loci in African-Americans (2013) (2)
- Cancer Epidemiology in the 21 st Century " Drivers " of Translational Cancer Epidemiology in the 21 st Century : Needs and Opportunities (2013) (2)
- Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2008) (1)
- Serum Insulin-like Growth Factor ( IGF ) and IGF-binding Protein Levels and Risk of Lung Cancer : A Case-Control Study Nested in the-Carotene and Retinol Efficacy Trial Cohort 1 (2002) (1)
- Nucleotide excision repair genes and lung cancer risk: A pathway-based approach (2005) (1)
- ‘Confounding’ Our Future (2011) (1)
- Abstract PR-03: Genetic variations in microRNA biogenesis genes as predictors for risk of second primary tumor (SPT) and/or recurrence in patients with early‐stage head and neck cancer (2010) (1)
- Abstract 5475: Wnt pathway pharmacogenetics in lung cancer patients treated with platinum regimens (2011) (1)
- Association between glutathione S-transferase (GST) P1 polymorphisms and survival of patients with advanced non-small cell lung cancer (NSCLC). (2004) (1)
- Abstract 1584: Transcriptome analysis links immune genes allelic expression imbalances to lung cancer (2019) (1)
- Abstract #LB-139: A comprehensive genome-wide association study of lung cancer (2009) (1)
- Abstract 4092: Aberrant miRNA methylation in tumors from surgically resected lung cancer patients and association with survival (2010) (1)
- Association between Low Dietary Folate Intake and Suboptimal Cellular DNA Repair Capacity 1 (2003) (1)
- Inflammation genes and pain severity in lung cancer patients. (2009) (1)
- Eleventh Annual AACR American Cancer Society Award for Research in Epidemiology or Prevention Lecture Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair 1,2 (2003) (1)
- Predictive Biomarkers and Personalized Medicine Genetic Variants in the PI 3 K / PTEN / AKT / mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor / Recurrence Risk and Response to Retinoid Chemoprevention (2012) (1)
- Abstract 287: Deletion of 3p22.1 by FISH in non-small cell lung cancer (NSCLC) is significantly correlated with loss of β-catenin membrane expression and dysregulated cell adhesion. (2013) (1)
- Abstract A127: Comparison of discriminatory power and accuracy of three lung cancer risk models (2010) (1)
- ABSTRACTS 32nd Annual Meeting • American Society of Preventive Oncology, Bethesda, Maryland • March 16-18, 2008 (2008) (1)
- Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors (2013) (1)
- Abstract 1675: Lung cancer chemotherapy: genetic variations in the transforming growth factor beta pathway as predictors of survival (2010) (1)
- Environmental carcinogenesis and its prevention: the head and neck cancer model. (1993) (1)
- Lung cancer and wood dust exposure (1995) (1)
- 1045 : p53 Polymorphisms Predict Poor Clinical Outcome in Non-Small-Cell Lung Cancer Patients Treated With Radiotherapy/Chemotherapy (2006) (1)
- Meta-and pooled analysis of GSTM 1 and CYP 1 A 1 polymorphisms and oropharyngeal cancer : a HuGE-GSEC review (2014) (1)
- Reply to K.A. Olaussen et al (2012) (1)
- Diet and physical activity in lung cancer risk prediction for current, former, and never smokers. (2007) (1)
- Molecular Epidemiology of Head and Neck Cancer (2003) (1)
- Phytoestrogens and Risk of Lung Cancer—Reply (2006) (1)
- Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility (2020) (1)
- Increased Risk of Lung Cancer DNA-Methyltransferase-3B Promoter Is Associated with an A Novel Polymorphism in Human Cytosine (2013) (0)
- 856: Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk (2005) (0)
- Integrative molecular epidemiology: From risk assessment to outcome prediction (2005) (0)
- 983: Bladder Cancer Predisposition: A Pathway-Based Approach to DNA Repair and Cell Cycle Control Genes (2006) (0)
- Human Papillomavirus Type 16 Infection and Squamous Cell Carcinoma of the Head and Neck in Never-Smokers : A Matched Pair Analysis 1 (2003) (0)
- Abstract 5229: Candidate gene analysis of exome sequencing data in smokers susceptible and resistant to chronic obstructive pulmonary disease (2016) (0)
- Multigenic and dietary analysis of bladder cancer risk on special reference on nucleotide excision repair and folate intake (2004) (0)
- Abstract B94: Pharmacogenetics of retinoid chemoprevention in head and neck cancer patients: Modulation of response by common genetic variation in the mTOR signaling pathway (2010) (0)
- Room 501 A-C, Los Angeles Convention Center Epidemiology 11 Inflammation, Immunity, and Novel Pathways (2007) (0)
- Correspondence re: M. T. Goodman et al., effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol. Biomark. Prev., 7: 113-117, 1998. (1998) (0)
- Abstract LB-400: Conventional and anti-microbial pesticide exposures and increased risk of lung cancer in Mexican Americans (2010) (0)
- Abstract 4662: Genetic variations in the cell-cycle pathway and survival of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy (2010) (0)
- Potential Susceptibility Markers For Lung Cancer -Radiation-induced G2 Delay, Apoptosis, and p53 Response as γ (2013) (0)
- Abstract 1899: Validation of the Spitz lung cancer risk prediction model with the Dutch-Belgian randomized lung cancer screening trial (NELSON) cohort (2011) (0)
- Pro-oxidants and Injury Effects : Contributors to Tobacco Carcinogenesis in the Lung ? (2005) (0)
- HighMutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage IIINon^Small Cell Lung Cancer Treatedwith Radiotherapy and Chemotherapy (2005) (0)
- Smoking Experimentation, Moderate-to-Vigorous Physical Activity, and Associated Psychosocial and Demographic Correlates among Mexican Origin Youth (2018) (0)
- The implementation and applications of a cancer patient risk evaluation questionnaire. (1989) (0)
- Erratum: XID/ERCC2 polymorphisms and risk of head and neck cancer: A case control analysis (Carcinogenesis (2000) vol. 21 (2219-2224)) (2001) (0)
- American Society of Cytopathology 56th Annual Scientific Meeting Platform and Poster Presentations (2008) (0)
- Single-Nucleotide Polymorphisms, DNA Repair, and Cancer (2003) (0)
- Abstract 4132: Expression of pattern recognition receptor genes and survival in colorectal adenocarcinoma (2014) (0)
- Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2016) (0)
- Pharmacogenetics of lung cancer: An integrative epidemiologic approach (2008) (0)
- Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
- Correction: Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2017) (0)
- Mutations in Nonmelanoma Skin Cancer of the Head and Neck : Molecular Evidence for Field Cancerization 1 (2006) (0)
- Abstract 4600: Target exome sequencing for disease-causing rare mutations in familial and sporadic lung cancer (2015) (0)
- Abstract 2929: Predictors of survival in never-smokers with non-small cell lung cancer: A large-scale, two-phase genetic study (2012) (0)
- Genetic variations in chemotherapy drug action pathways modulate therapeutic response in esophageal cancer (2005) (0)
- Abstract LB-406: A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity and cancer risk (2010) (0)
- O-053 Building a comprehensive quantitative risk assessment modelfor lung cancer (2005) (0)
- Use of telomere length in peripheral leukocytes to predict risk of recurrence in patients with early-stage non-small cell lung cancer after curative resection. (2010) (0)
- Abstract CN14-01: A genome-wide association study identifies variation in nicotine acetylcholine receptors that influence risk for lung cancer and smoking behavior (2008) (0)
- Abstract B109: Tea and coffee consumption, DNA repair, and lung cancer risk (2010) (0)
- An informatics tool to assess colon cancer risk. (2005) (0)
- Expressionof Telomere-AssociatedGenes as PrognosticMarkers for Overall Survival in Patients with Non ^ Small Cell Lung Cancer (2006) (0)
- Abstract 2849: A functional promoter variant (rs2075533 C>T) inTNFSF8 involved in apoptosis contributes to decreased risk of lung cancer — a finding from Texas lung cancer genome-wide association study (2010) (0)
- Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort (2012) (0)
- Abstract 2879: Profiling of lung microbial communities in lung cancer and chronic obstructive pulmonary disease patients (2015) (0)
- An Epidemiologic Approach to Outcome Prediction (2006) (0)
- Early cancer detection: update for primary-care physicians. (1990) (0)
- Abstract 4662: Genetic predictors of clinical outcomes for patients with non-small cell lung cancer (2011) (0)
- Age and gender differences in the association between MPO 463>A and lung cancer. Results from the genetic susceptibility to environmental carcinogens pooled analysis (2006) (0)
- ' s response to reviews Title : Correlates of cognitive susceptibility to smoking among Mexican origin youth residing in (2008) (0)
- 3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC) (2007) (0)
- Abstract A6: Ethnic differences in risk of lung cancer associated with repair capacity for tobacco carcinogen‐induced DNA adduct (2010) (0)
- Genome-wide association study confirms lung cancer susceptibility loci on chromosome 5p15 and 15q25 in an African-American population (2016) (0)
- Erratum: Reduced expression levels of nucleotide excision repair genes in lung cancer: A case-control analysis (Carcinogenesis (2000) vol. 21 (1527-1530)) (2001) (0)
- Response: Re: Benzo[a]pyrene Diol Epoxide and Bleomycin Sensitivity and Susceptibility to Cancer of Upper Aerodigestive Tract (1999) (0)
- 31st Annual Meeting • American Society of Preventive Oncology, Houston, Texas • March 2–4, 2007 (2007) (0)
- Death Receptor 4 and Bladder Cancer Risk 1 (2003) (0)
- Abstract A106: Optimal strategies for selecting samples for sequencing families with a common cancer: The Genetic Epidemiology of Lung Cancer Consortium. (2012) (0)
- Gender-specific effects of dietary carotenoid intake on lung cancer risk (2007) (0)
- Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk. (2003) (0)
- Abstract 857: A preliminary study of the correlation of tumor size and epidemiological characteristics in patients with non-small cell lung cancer (2010) (0)
- Parental electromagnetic exposures and childhood cancer (1986) (0)
- Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2013) (0)
- Abstract B136: Early age at menarche in Mexican American girls: Psychosocial risk factors (2010) (0)
- E-76.Identifying the high risk subject: Assessment of DNA damage and repair (2003) (0)
- Breakfast Consumption Among Mexican American Adolescents (2012) (0)
- Abstract LB-186: Genetic variants and risk of lung cancer in never-smokers: A genome-wide association study (2010) (0)
- Abstract 4149: Genetic variation in CYP2A6, a nicotine/nitrosamine metabolism enzyme, influences lung cancer risk in two independent case-control studies of African American smokers (2014) (0)
- Abstract 1878: Evidence for the indirect relationship between self-reported exposure to environmental agents and smoking in the assessment of lung cancer risk (2011) (0)
- Association of dietary magnesium and DNA repair capacity with lung cancer risk. (2006) (0)
- 4–2 Smoking and survival after breast cancer diagnosis (2008) (0)
- Continued increase of testicular cancer in the United States (1994) (0)
- Atlas do cancro em Portugal, 1980–82 (2004) (0)
- Abstract IA21: Risk prediction models for lung cancer (2012) (0)
- Title: Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility (2020) (0)
- Abstract #SY31-3: Lung cancer, smoking, and genetic susceptibility in African Americans (2009) (0)
- Re: Identifying Mexican Americans. (1987) (0)
- Chapter 17 SINGLE-NUCLEOTIDE POLYMORPHISMS , DNA REPAIR , AND CANCER (0)
- ERRATUM (2000) (0)
- Encouraging trends in lung cancer mortality in Texas, 1970 to 1986. (1989) (0)
- Abstract B91: Self-reported prior lung disease as risk factors for non-small cell lung cancer in Mexican Americans (2011) (0)
- Abstract 938: Inflammation and immune response pathway analysis of lung cancer using hierarchal modeling based on GWAS data (2010) (0)
- Re: Benzo[α]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract [5] (multiple letters) (1999) (0)
- C8-04: Genetic polymorphisms in cell cycle control pathways and lung cancer risk (2007) (0)
- Mutagen Sensitivity (MS) may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy. (2004) (0)
- Genetic susceptibility to tobacco carcinogenesis: An integrative epidemiologic approach. (2006) (0)
- Sex ratio of offspring of patients with prostatic cancer. (1986) (0)
- Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever. (2013) (0)
- Abstract 4657: Identification and validation of genetic determinants of DNA repair phenotype in genome-wide association study of lung cancer (2011) (0)
- AP2β nucleolar localization predicts poor survival after stage I non–small cell lung cancer resection (2012) (0)
- A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility 1 (2001) (0)
- The influence of polymorphisms in cytokine genes on pain and response to analgesia in lung cancer patients receiving palliative treatment (2008) (0)
- Lung cancer risk prediction models for Mexican Americans and African Americans (2007) (0)
- Willingness to provide biologic samples: results from a healthy urban population of Mexicans and Mexican-Americans in Texas (2003) (0)
- Mutagen sensitivity predicts poor overall and disease specific survival in patients with stage III non-small cell lung cancer treated with chemo/radiotherapy (2004) (0)
- ACase – Control Study of a Sex-Speci fi c Association between a 15 q 25 Variant and Lung Cancer Risk (2011) (0)
- Statistical models for analysis of cytogenetic biomarkers. (2000) (0)
- Erratum to: Assessing environmental and occupational risk factors for lung cancer in Mexican–Americans (2011) (0)
- Whole Exome Sequencing Analysis Of Severe COPD (2017) (0)
- COMMENT ON: MUTAGEN SENSITIVITY AS A RISK FACTOR FOR SECOND MALIGNANT TUMORS FOLLOWING MALIGNANCIES OF THE UPPER AERODIGESTIVE TRACT. AUTHORS' REPLY (1995) (0)
- Cytokine gene polymorphisms and cancer-related symptoms in lung cancer patients (2007) (0)
- Case control analysis of neuroblastoma and paternal occupation (1985) (0)
- Abstract 1174: Genetic variations in microRNA biogenesis pathway genes as susceptibility loci for lung cancer risk (2011) (0)
- Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2016) (0)
- Abstract 879: Mitochondrial DNA content and its association with lung cancer risk and clinical outcomes (2010) (0)
- NNK-induced DNA damage as measured by the comet assay is a marker of lung cancer risk (2008) (0)
- Agreement between child and mother ’ s self-reports and mother – mother self-reports on mother ’ s current smoking (0)
- Lung and breast cancer death rates in Texas women. (1986) (0)
- Associations between genetic polymorphisms and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with paclitaxel-based therapy (2008) (0)
- Association of genetic variations in DNA-methyltransferases, histone-methyltransferases, and methylated DNA-binding proteins with recurrence and survival in early-stage non-small cell lung cancer treated with surgery alone or surgery and chemotherapy. (2010) (0)
- Abstract IA15: Role of environment in genetic predisposition: Lessons from tobacco studies (2020) (0)
- BRCA2-branching out too? (2015) (0)
- Abstract 889: An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for theXRCC4SNPs (2011) (0)
- Lymphocyte mutagen sensitivity correlates significantly with gender, histology, and radiation toxicity in lung cancer patients (2000) (0)
- Abstract A86: Psychosocial and genetic determinants of cigarette experimentation in Mexican heritage youth (2010) (0)
- Abstract LB-334: Functional polymorphisms in the stem-cell related pathway affect susceptibility to non-small cell lung cancer: a finding from Texas lung cancer genome-wide association study (2012) (0)
- Abstract LB-441: The genome wide gene-environment interaction analysis for asbestos exposure on lung cancer susceptibility (2011) (0)
- Smoking Susceptibility in Mexican Origin Youth: Family and Community Factors (2006) (0)
- Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. (1996) (0)
- The authors reply. (2015) (0)
- Association between Family History Sensitivity in Upper Aerodigestive (1993) (0)
- Germline Predictors of Outcome in Non-small Cell Lung Cancer (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Margaret R. Spitz?
Margaret R. Spitz is affiliated with the following schools: